India is reevaluating its position in global health frameworks as the World Health Organization (WHO) faces increasing criticism for its growing alignment with powerful donors like the Bill & Melinda Gates Foundation and Bloomberg Philanthropies. With major countries like the United States pulling away, the WHO’s ability to act as a neutral body has come into question.
For India, a nation with diverse health challenges, these donor-driven policies are often misaligned with local needs. This is especially true in the realm of tobacco control, where India’s large population of smokeless tobacco users faces challenges with global health policies that fail to consider local realities.
India has a long history of defying external pressures to prioritize its own health needs. From providing affordable generics during the HIV/AIDS crisis to leading the call for vaccine equity during the COVID-19 pandemic, India’s innovative, localized approach has been a key driver in its health successes. However, global frameworks, such as the WHO’s tobacco control measures, are often seen as out of touch with India’s unique health landscape.
